The novel catecholaminergic and serotoninergic activity enhancer R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes

Neuroscience Letters

Volumn 328, Issue 3, 2002, Pages 205-208

  Ohta, Kiyoe ^a   Ohta, Mitsuhiro ^a,b   Mizuta, Ikuko ^a   Fujinami, Aya ^b   Shimazu, Seiichiro ^c   Sato, Noriyuki ^c   Yoneda, Fumio ^c   Hayashi, Kyozo ^d   Kuno, Sadako ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c Fujimoto Pharmaceutical Corporation   (Japan)

^d GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Astrocyte; Brain derived neurotrophic factor; Glial cell line derived neurotrophic factor; Nerve growth factor; Parkinson's disease; R ( ) 1 (benzofuran 2 yl) 2 propylaminopentane; Selegiline

Indexed keywords

1 (BENZOFURAN 2 YL) 2 PROPYLAMINOPENTANE; BENZOFURAN DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; DACTINOMYCIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CATECHOLAMINERGIC SYSTEM; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONINERGIC SYSTEM; TIME; TRANSCRIPTION TERMINATION;

ANIMALS; ASTROCYTES; BENZOFURANS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOLAMINES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MICE; MICE, INBRED ICR; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN; UP-REGULATION;

EID: 0037119165     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00461-5     Document Type: Article

References (20)

1. The transforming growth factor-βs. Structure, signaling and roles in nervous system. Development and functions
2. Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons
3. (-)-1-(Benzofuran-2-yl)-2-propylaminopentane shows survival effect on cortical neurons under serum-free condition through sigma receptors
4. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
5. Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rotational for prophylactic (-)deprenyl (selegiline) medication
6. (-)-1-(Benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain
7. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
8. Neurotrophic factors: From molecule to man
9. GDNF and NT-4 protect midbrain dopaminergic neurons from toxic damage by iron and nitric oxide
10. Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes
11. Changes in cytokines and neurotrophins in Parkinson's disease
12. Medial nigral dopamine neurons have rich neurotrophin support in humans
13. Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes
14. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra
15. (-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release
16. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons
17. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration
18. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
19. GDNF: A novel factor with therapeutic potential for neurodegenerative disorders
20. Structure-activity studies leading to (-)-1-(benzofuran-2-yl)-2-propylaminopentane, (-)-BPAP, a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain